| 1 |
Fricker, G. and Drewe, J., Current concepts in intestinal peptide absorption. J. Pept. Sci., 2, 195-211 (1996)
DOI
PUBMED
|
| 2 |
Kohler, E., Duberow, D. M., Drew, J., Ribes, G., Loubatieres, M. M. M., Mazer, N., Gyr, K., and Berlinger, C., Absorption of an aqueous solution of a new synthetic somatostatin analogue administered to man by gavage. Eur. J. Clin. Pharmacol.. 33, 167-171 (1987)
DOI
ScienceOn
|
| 3 |
Rubinstein, A, Approaches and opportunities in colon-specific drug delivery. Crit. Rev. Ther. Drug Carrier Syst., 12, 101-149 (1995)
DOI
PUBMED
ScienceOn
|
| 4 |
Bernkop-Schnurch, A., Chitosan and its derivatives: potential excipients for peroral peptide delivery systems. Int. J. Pharm., 194, 1-13 (2000)
DOI
PUBMED
ScienceOn
|
| 5 |
Babiuk, S., Baca-Estrada, M., Babiuk, L. A., Ewen, C., and Foldvari, M., Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery. J. Control Release., 66,199-214 (2000)
DOI
ScienceOn
|
| 6 |
Gregg, C. R., Drug interactions and anti-infective therapies. Am. J. Med., 106, 227-237 (1999)
DOI
PUBMED
ScienceOn
|
| 7 |
Lundin, S. and Vilhardt, H., Absorption of 1-deamino-8-D-arginine vasopressin from different regions of the gastrointestinal tract in rabbits. Acta Endocrinol., 112, 457-460 (1986)
PUBMED
|
| 8 |
Anderson, P. M., Hanson, D. C., Hasz, D. E., Halet, M. R., Blazer, B. R, and Ochoa, A. C., Cytokines in liposomes: preliminary studies with IL-1, IL-2, IL-6, GM-CSF and interferon-gamma. Cytokine, 6, 92-101, (1994)
DOI
ScienceOn
|
| 9 |
Bai, J. P., Chang, L. L., and Guo, J. H., Targeting of peptide and protein drugs to specific sites in the oral route. Crit. Rev. Ther. Drug. Carrier. Syst.. 12, 339-371 (1995)
PUBMED
|
| 10 |
Bickel, U., Yoshikawa, T., and Pardridge, W. M., Delivery of peptides and proteins through the blood-brain barrier. Adv. Drug Deliv. Rev., 46, 247-279 (2001)
DOI
PUBMED
ScienceOn
|
| 11 |
Burke, C. J., Hsu, T. A., and Volkin, D. B., Formulation, stability, and delivery of live attenuated vaccines for human use. Crit. Rev. Ther. Drug Carrier Syst., 16, 1-83 (1999)
PUBMED
|
| 12 |
Carreno-Gomez, B., Woodley, J. F., and Florence, A. T., Studies on the uptake of tomato lectin nanoparticles in everted gut sacs. Int. J. Pharm., 183,7-11 (1999)
DOI
ScienceOn
|
| 13 |
Cornell, R. and Padykula, H. A., A cytological study of intestinal absorption in the suckling rat. Am. J. Anst., 125, 291-316 (1969)
DOI
ScienceOn
|
| 14 |
Fasano, A., Modulation of intestinal permeability: an innovative method of oral drug delivery for the treatment of inherited and acquired human diseases. Mol. Genet. Metab., 64, 12-18 (1998c)
DOI
PUBMED
ScienceOn
|
| 15 |
Fromm, M. F., P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs. Int. J. Clin. Pharmacol. Ther., 38, 69-74 (2000)
DOI
PUBMED
|
| 16 |
Jani, P., Halbert, G. W., Langridge, J., and Florence, T., The uptake and translocation of latex nanospheres and microspheres after oral administration to rats, J. Pharm. Pharmacol., 41, 809-812 (1989)
DOI
PUBMED
|
| 17 |
Gonnella, P. A. and Neutra, M. R., Membrane-bound and fluid-phase macromolecules enter separate prelysosomal compartments in absorptive cells of suckling rat ileum. J. Cell Biol., 99, 909-917 (1984)
DOI
ScienceOn
|
| 18 |
Gutniak, M. K., Larsson, H., Heiber, S. J., Juneskans, O. T., Holst, J. J., and Ahren, B. Potential therapeutic levels of glucagon-like peptide I achieved in humans by a buccal tablet. Diabetes Care, 19,843-848 (1996)
DOI
ScienceOn
|
| 19 |
Harris, R. Z., Benet, L. Z., and Schwartz, J. B., Gender effects in pharmacokinetics and pharmacodynamics. Drugs, 50, 222-239 (1995)
DOI
ScienceOn
|
| 20 |
Kreuter, J., Peroral administration of nanoparticles. Adv. Drug Deliv. Rev., 7, 71-86 (1991)
DOI
ScienceOn
|
| 21 |
Kurosaki, Y and Kimura, T., Regional variation in oral mucosal drug permeability. Crit. Rev. Ther. Drug Carrier Syst., 17, 467-508 (2000)
PUBMED
|
| 22 |
Lasic, D.D. and Papahadjopoulos, D., Liposomes revisited. Science, 267, 1275-1276 (1995)
DOI
PUBMED
ScienceOn
|
| 23 |
Lee, V. H. L., Protease inhibitors and penetration enhancers as approaches to modify peptide absorption. J. Control. Rel., 13, 213-223 (1991)
|
| 24 |
Lee, H.J., Riley, G., Johnson, O., Cleland, J. L., Kim, N., Charnis, M., Baily, L., Duenas, E., Shahzamani, A., Marian, M., Jones, A.J.S., and Putney, S. D. In vivo characterization of sustained-release formulations of human growth hormone, J. Pharmacol. Exp. Ther., 281, 1431-1439 (1997)
PUBMED
|
| 25 |
Mactarlane, G. T, Cummings, J. H., Macfarlane, S., and Gibson, G. R, Influence of retention time on degradation of pancreatic enzymes by human colonic bacteria grown in a 3-stage continuous culture system, J. App. Bact., 67, 520-527 (1989)
|
| 26 |
Samanen, J., Wilson, G., Smith, P. L., Lee, C. P, Bondinell, W, Ku, T, Rhodes, G., and Nichols, A, Chemical approaches to improve the oral bioavailability of peptidergic molecules. J. Pharm. Pharmacol., 48, 119-135 (1996)
DOI
PUBMED
|
| 27 |
Oh, D. M., Han, H. K., and Amidon, G. L., Drug transport and targeting. Intestinal transport.. Pharm. Biotechnol., 12, 59-88 (1999)
PUBMED
|
| 28 |
Quintanar-Guerrero, D., Allemann, E., Fessi, H., and Doelker, E., Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers. Drug Dev .lnd. Pharm., 24, 1113-1128 (1998)
DOI
ScienceOn
|
| 29 |
Russell-Jones, G. J., Arthur, L., and Walker, H., Vitamin  mediated transport of nanoparticles across Caco-2 cells. Int. J. Pharm. 179, 247-255 (1999)
DOI
ScienceOn
|
| 30 |
Tanaka, E., Gender-related differences in pharmacokinetics and their clinical significance. J. Ciln. Pharm. Ther., 24, 339-346 (1999)
DOI
PUBMED
ScienceOn
|
| 31 |
Thurmann, P. A. and Hompesch, B. C., Influence of gender on the pharmacokinetics and pharmacodynamics of drugs. Int. J. Clin. Pharmacol. Ther., 36, 586-590 (1998)
PUBMED
|
| 32 |
Tsuji, A. and Tamai, I., Carrier-mediated intestinal transport of drugs. Pharm. Res., 13, 963-977 (1996)
DOI
ScienceOn
|
| 33 |
Vyas, S. P., Venugopalan, P., Sood, A., and Mysore, N., Some approaches to improve bioavailability of peptides and proteins through oral and other mucosal routes. Pharmazie., 52, 339-345 (1997)
PUBMED
|
| 34 |
Walker, G. F, Langoth, N., and Bernkop-Schnurch, A., Peptidase activity on the surface of the porcine buccal mucosa. lnt. J. Pharm., 21, 233, 141-147 (2002)
|
| 35 |
Nagai, T, Drug delivery systems by controlled release. Yakugaku Zasshi, 108, 613-624 (1988)
DOI
PUBMED
|
| 36 |
Yamamato, A., Taniguchi, T, Rikyuu, K., Tsuji, T, Fujita, T, Murakami, M., and Muranishi, J., Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats. Pharm. Res., 11, 1496-1500 (1994)
DOI
ScienceOn
|
| 37 |
Picsitelli, S. C., Reiss, W G., Figg, W D., and Petros, W P., Pharmacokinetics studies with recombination cytokines. Scinetific issues and practical considerations. Clin. Pharmacokinet., 32, 368-381 (1997)
DOI
ScienceOn
|
| 38 |
Thomas, N. W., Jenkins, P G., Howard, K. A., Smith, M. W., Lavelle, E. C., Holland, J., and Davis, S. S., Particle uptake and translocation across epithelial membranes. J. Anat., 189, 487-490 (1996)
PUBMED
|
| 39 |
Russell-Jones, G. J., Use of vitamin conjugates to deliver protein drugs by the oral route. Crit. Rev. Ther. Drug Carrier Syst., 15,557-586 (1998)
PUBMED
|
| 40 |
Woodley, J. F, Enzymatic barriers for GI peptide and protein delivery. Crit. Rev. Ther. Drug Carrier Syst., 11, 61-95 (1994).
PUBMED
|
| 41 |
Alur, H., Beal, J.D., Pather, S. I., Mitra, A. K, and Johnston, T. P, Evaluation of a novel, natural oligosaccharide gum as a sustained-release and mucoadhesive component of calcitonin buccal tablets. J. Pharm. Sci., 88,1313-1319 (1999)
DOI
ScienceOn
|
| 42 |
Ray, R, Novak, M., Duncan, J. D., Matsuoka, Y, and Compans, R W., Microencapsulated human parainfluenza virus induces a protective immune response. J. Infect. Dis. 167, 752-755 (1993)
DOI
PUBMED
ScienceOn
|
| 43 |
Su, S.-F, Amidon, G. L., and Lee, H. J., The intestinal metabolism and absorption of cholecystokinin analogs in rats. Biochem. Biophys. Res. Commun. 292, 632-638. (2002)
DOI
ScienceOn
|
| 44 |
Wacher, V. J., Salphati, L., and Benet, L. Z., Active secretion and enterocytic drug metabolism barriers to drug. Adv. Drug Deliv. Rev., 46, 89-102 (2001)
DOI
ScienceOn
|
| 45 |
Fasano, A., Novel approaches for oral delivery of macromolecules. J. Pharm. Sci., 87, 1351-1356 (1998a)
DOI
PUBMED
|
| 46 |
Ye, Q., Asherman, J., Stevenson, M., Brownson, E., and Katre, N. V., DepoFoa technology: a vehicle for controlled delivery of protein and peptide drugs. J. Control. Rel, 64, 155-166 (2000)
DOI
ScienceOn
|
| 47 |
Baluom, M., Friedman, D. I., and Rubinstein, A., Absorption enhancement of calcitonin in the rat intestine by carbopol-containing submicron emulsions. Int. J. Pharm., 154, 235-243 (1997)
DOI
ScienceOn
|
| 48 |
Grevel, J., Nuesch, E., Abisch, E., and Kutz, K., Pharmacokinetics of oral cyclosporin A (Sandimmun) in healthy subjects. Eur. J. Clin. Pharmacol., 31,211-216 (1986)
DOI
ScienceOn
|
| 49 |
Lehr, C. M., Bioadhesion technologies for the delivery of peptide and protein drugs to the gastrointestinal tract. Crit. Rev. Ther. Drug Carrier Syst., 11, 119-160 (1994)
PUBMED
|
| 50 |
Allen, A., Cuncliffe, W. J., Peerson, J. P, Sellers, L. A., and Ward, R, Studies on gastrointestinal mucus. Scan. J. Gastroenterol., 19 (suppl), 101-113 (1984)
|
| 51 |
Fasano, A., Innovative strategies for the oral delivery of drugs and peptides. Trends Biotechnol., 16, 152-157 (1998b)
DOI
PUBMED
ScienceOn
|
| 52 |
Kararli, T. T., Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm. Drug Dispos., 16, 351-380 (1995)
DOI
PUBMED
ScienceOn
|
| 53 |
Lee, H. J. and Amidon, G. L., The effect of enzyme inhibitor and absorption site following [D-al , D-le ]enkephalin oral administration in rats. Biopharm. Drug Dispos. 23, 131-141 (2002)
DOI
ScienceOn
|
| 54 |
Mestscky, J., Michalek, S. M., Moldoveanu, Z., and Russell, M. W, Routes of immunization and antigen delivery systems for cotimal mucosal immune responses in humans. Behring. Int. Mitt., 98, 33-43 (1997)
|
| 55 |
Allemann, E., Gurney, R., and Doelker, E., Drug loaded nanopaticles-preparation methods and drug targeting issues. Eur. J. Pharm. Biopharm., 39,173-191 (1993)
|
| 56 |
Bernkop-Schnurch, A, Bratengeyer, I., and Valenta, C., Development and in vitro evaluation of a drug delivery system protecting from trypsinic degradation. Int. J. Pharm., 157, 17-25 (1997b)
DOI
ScienceOn
|
| 57 |
Lehr, C. M., Bouwstra, J. A., Tukker, J. J., and Junginger, H. E., Intestinal transit of bioadhesive microspheres in an in situ loop in the rat. A comparative study with polymers and blends based on poly(acrylic acid). J. Control. ReI., 13, 51-62 (1990)
DOI
ScienceOn
|
| 58 |
Miller, D. B., and Spence, J. D., Clinical Pharmacokinetics of Fibric Acid Derivatives (Fibrates). Clin. Pharmacokinet., 34, 155-162 (1998)
DOI
ScienceOn
|
| 59 |
Sakuma, S., Hayashi. M., and Akashi, M., Design of nanoparticles composed of graft copolymers for oral peptide delivery. Adv. Drug Deliv. Rev., 47, 21-37 (2001)
DOI
ScienceOn
|
| 60 |
Saffran, M., Kumar, G.S., Savariar, C., Burnham, J. C., William, F., and Neckers, D. C., A new approach to the oral administration of insulin and other peptide drugs. Science. 233, 1081-1084 (1986)
DOI
PUBMED
|
| 61 |
Kennedy, A. R., The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent. Am. J. Clin. Nutr., 68, 1406S-1412S (1998)
PUBMED
|
| 62 |
Bernkop-Schnurch, A., Schwarz, G. H., and Kratzel, M., Modified mucoadhesive polymers for the peroral administration of mainly elastase degradable therapeutic (poly)peptides. J. Cont. Rel., 47, 113-121, (1997a)
DOI
ScienceOn
|
| 63 |
Foradori, A., Mezzano, S., Videla, C., Pefaur, J., and Elberg, A., Modification of the pharmacokinetics of cyclosporine A and metabolites by the concomitant use of Neoral and diltiazem or ketoconazole in stable adult kidney transplants. Transplant Proc., 30,1685-1687 (1998)
DOI
ScienceOn
|
| 64 |
Keljo, D. J., Hamilton, J. R., Quantitative determination of macromolecular transport rate across intestinal Peyers patches. Am. J. Physiol., 244, G637-G644 (1983)
PUBMED
|
| 65 |
Nakane, S., Kakumoto, M., Yukimatsu, K. and Chien, Y W, Oramucosal Delivery of LHRH: Pharmacokinetic Studies of Controlled and Enhanced Transmucosal Permeation. Pharm. Dev. Technol., 1, 251-259 (1996)
DOI
ScienceOn
|
| 66 |
New, R. R. C., Guard, P. W., Littlewood, G. M., Sandbank, B. M., and Flynn, M. J., Administration of calcitonin to humans: comparison of intra-nasal and oral routes. Third European Symposium on Controlled Release Drug Delivery, Noordwijk aan Zee, The Netherlands, April 6-8 (1994)
|
| 67 |
Watts, T L., and Fasano, A., Modulation of intestinal permeability: a novel and innovative approach for the oral delivery of drugs, macromolecules and antigens. Biotechnol. Genet. Eng. Rev., 17, 433-453 (2000)
DOI
PUBMED
ScienceOn
|
| 68 |
Yang, C. Y, Dantzig, A. H., and Pidgeon, C., Intestinal peptide transport systems and oral drug availability. Pharm. Res., 16, 1331-1343 (1999)
DOI
ScienceOn
|
| 69 |
Fix, J. A., Oral controlled release technology for peptides: status and future prospects. Pharm. Res., 13, 1760-1764 (1996)
DOI
PUBMED
ScienceOn
|
| 70 |
Suzuki, H., and Sugiyama, Y, Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine. Eur. J. Pharm. Sci., 12,3-12 (2000)
DOI
ScienceOn
|
| 71 |
Lee, H. J. and Lee, M. G. Controlling absorption site, metabolism, and membrane permeability in the intestine to develop strategies for protein drug oral delivery. Abstract submitted for the 16th annual meeting of the AAPS to be held in Toronto, Canada in November, 2002
|
| 72 |
Leone-Bay, A, Paton, D. R, and Weidner, J. J., The development of delivery agents that facilitate the oral absorption of macromolecular drugs. Med. Res. Rev., 20, 169-186 (2000)
DOI
ScienceOn
|
| 73 |
Schellens, J. H., Malingre, M. M., Kruijtzer, C. M., Bardelmeijer, H.A, Van Tellingen, O., Schinkel, A. H., and Beijnen, J. H., Modulation of oral bioavailability of anticancer drugs: from mouse to man. Eur. J. Pharm. Sci., 12, 103-110 (2000)
DOI
ScienceOn
|
| 74 |
Ariomori, K. and Nakano, M., Drug Exsorption from Blood into the Gastrointestinal Tract. Pharm. Res., 15, 371-376 (1998)
DOI
ScienceOn
|
| 75 |
Fojo, A. T., Ueda, K., Slamon, D. J., Poplack, D. G., Gottesman, M. M., and Pastan, I., Expression of a multidrug-resistance gene in human tumors and tissues. Proc. Natl. Acad. Sci. USA, 84, 265-269 (1987)
DOI
ScienceOn
|
| 76 |
O’Hagan, D.T., Microparticles as oral vaccines, in Novel Delivery Systems for Oral Vaccines (O’Hagan, D. T., ed.), CRC Press, Boca Raton, FL; CRC Press, pp. 188-197., 1994
|
| 77 |
Eldridge, J. H., Hammond, C. J., Meulbroek, J. A., Staas, J. K., Gilley, R M., and Tice, T. R, Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microsphere target the Peyers patches, J. Control. Rel., 11, 205-214 (1990)
DOI
ScienceOn
|
| 78 |
Scrips Report, Biopharmaceuticals: a new era of discovery in the biotechnology revolution. PJB Publications ltd., Surray, UK, (2001)
|
| 79 |
Senel, S., Kremer, M., Nagy, K., and Squier, C., Delivery of bioactive peptides and proteins across oral (buccal) mucosa. Curr. Pharm. Biotechnol., 2, 175-186 (2001)
DOI
ScienceOn
|
| 80 |
DeVane, C. L. and Gill, H. S., Clinical pharmacokinetics of fluvoxamine: applications to dosage regimen design. J. Clin. Psychiatry., 58, 7-14 (1997)
PUBMED
|
| 81 |
Woodley, J. F., Peptidase enzymes of G.I. tract; barriers to peptide delivery, but potential for controlled release. Proc. Int. Symp. Control Rel. Bioact. Mater., 19, 2-5, (1992)
|
| 82 |
Beierls, I., Meibohm, B., and Derendorf, H., Gender differences in pharmacokinetics and pharmacodynamics. Int. J. Clin. Pharmacol. Ther., 37, 529- (1999)
PUBMED
|
| 83 |
Spahn-Langguth, H., and Langguth, P, Grapefruit juice enhances intestinal absorption of the P-glycoprotein substrate talinolol. Eur. J. Pharm. Sci., 12, 361-367 (2001)
DOI
ScienceOn
|
| 84 |
Jung, T., Kamm, W., Breitenbach, A., Kaiserling, E., Xiao, J. X., and Kissel, T., Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake? Eur. J. Pharm. Biopharm., 50, 147-160 (2000)
DOI
ScienceOn
|
| 85 |
Wacher, V. J., Silverman, J. A., Zhang, Y, and Benet, L, Z., Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics. J. Pharm. Sci., 87, 1322-1330 (1998)
DOI
PUBMED
|
| 86 |
Gonnella, P. A., Siminoski, K., Murphy, R. A., and Neutra, M. R., Transepithelial transport of epidermal growth factor by absorptive cells of suckling rat ileum. J. Clin. Invst., 80, 22-32 (1987)
DOI
ScienceOn
|
| 87 |
Paine, M. F., Khalight, M., Fisher, J. M., Shen, D. D., Kunze, K. L., Marsh, C. L., Perkins, J. D., Thummel, K. E. Characterization of intestinal and intraintestinal variations in human CYP3A-dependent metabolism. J. Pharmacal. Exp. Ther., 283, 1552-1562 (1997)
|
| 88 |
Park, K. and Robinson, J. R, Bioadhesive polymers as platforms for oral-controlled drug-delivery: method to study bioadhesion. lnt. J. Pharm., 19, 107-127 (1984)
DOI
ScienceOn
|
| 89 |
Torres-Lugo, M. and Peppas, N. A., Transmucosal delivery systems for calcitonin: a review. Biomaterials, 21, 1191-1196 (2000)
DOI
ScienceOn
|
| 90 |
Van Asperen, J., Van Tellingen, O., and Beijnen, J. H., The pharmacological role of P-glycoprotein in the intestinal epithelium. Pharmacol. Res., 37, 429-435 (1998)
DOI
ScienceOn
|
| 91 |
Corbett, J., and Ross, K., Neoral: the new cyclosporine. ANNA. J., 25, 71-72 (1998)
PUBMED
|
| 92 |
Garrido, A. B. Jr., Freeman, H.J., and Kim, Y.S., Amino acid and peptide absorption in bypassed jejunum following jejunoileal bypass in rats. Dig. Di. Sci., 26, 107-112, (1981)
DOI
ScienceOn
|
| 93 |
Merkle, H. P, New aspects of pharmaceutical dosage forms for controlled drug delivery of peptides and proteins. Eur. J. Pharm. Sci., 2, 19-21 (1994)
DOI
ScienceOn
|
| 94 |
Kompella, U. B. and Lee, V. H., Delivery systems for penetration enhancement of peptide and protein drugs: design considerations. Adv. Drug Deliv. Rev., 46, 211-245 (2001)
DOI
PUBMED
ScienceOn
|
| 95 |
Mannino, R. J. and Gould-Fogerite S., Lipid matrix-based vaccines for mucosal and systemic immunization. Pharm. Biotechnol., 6, 363-387 (1995)
PUBMED
|
| 96 |
DiBiase, M. D., and Morrel, E. M., Oral delivery of microencapsulated proteins. Pharm. Biotechnol., 10, 255-288 (1997)
PUBMED
|
| 97 |
Lee, V. H. L., Membrane transporters. Eur. Pharm. Sci., 11, S41-50 (2000)
DOI
ScienceOn
|
| 98 |
Leone-Bay, A., Ho, K.K., Agarwal, R., Baughman, R. A., Chaudhary, K., De Morin, F., Genoble, L., Mcinnes, C., Lercara, C., Milstein, S., OToole, D., Sarubbi, D., Variano, B., ard Paton, D. R. 4-[4-[(2-hydroxybenzoyl)amino]phenyl]butyric acid as a novel oral delivery agent for recombinant human growth hormone, J. Med. Chem., 39, 2571-2578 (1996)
DOI
ScienceOn
|
| 99 |
Habberfield, A., Jensen-Pippo, K., Ralph, L., Westwood, S., and Russel-Jones, G. J., Vitamin -mediated uptake of recombinant therapeutic proteins from the gut. Int. J. Pharm., 145,1-8 (1996)
DOI
ScienceOn
|
| 100 |
Lipka, E., Crison, J., and Amidon, G. L., Transmembrane transport of peptide type compounds : Prospects for oral delivery. J. Control. Rel., 39, 121-129 (1996)
DOI
ScienceOn
|
| 101 |
Stoll, B. R., Leipold, H. R., Milstein, S., and Edwards, D. A., A mechanistic analysis of carrier-mediated oral delivery of protein therapeutics. J. Control. Rel., 64, 217-228 (2000)
DOI
ScienceOn
|
| 102 |
Vaes, G., Digestive capacity of Iysosomes, In Hers, H. G. and Van Hoof, F (Eds.). Lysosomes and Storage Diseases, Academic Press, London, pp. 43-59, (1973)
|
| 103 |
Ower, R. L. and Bhalla, D. K., Cytochemical analysis of alkaline phosphatase and esterase activities and of lectin-binding and anionic sites in rat and mouse Peyers patch M-cells. Am. J. Anat., 168, 199-212 (1983)
DOI
ScienceOn
|
| 104 |
Verbeeck, C. K. and Horsmans, Y., Effect of hepatic insufficiency on pharmacokinetics and drug dosing. Pharm. World Sci., 20, 183-192 (1998)
DOI
ScienceOn
|
| 105 |
Wasan, K. M., Formulation and physiological and biopharmaceutical issues in the development of oral lipid-based drug delivery systems. Drug Dev. Ind. Pharm., 27, 267-276 (2001)
DOI
PUBMED
ScienceOn
|
| 106 |
Larkins, B. A., Pedersen, K., Marks, M.D., and Wilson, D. R., The zein proteins of maize endosperm. Trends Biochem. Sci., July, 306-308 (1984)
DOI
ScienceOn
|
| 107 |
Takeuchi, H., Yamamoto, H., and Kawashima, Y., Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv. Drug Deliv. Rev., 47, 39-54 (2001)
DOI
ScienceOn
|
| 108 |
Cleland, J. L., Daugherty, A., and Mrsny, R, Emerging protein delivery methods. Curr. Opin Biotechnol., 12, 212-219 (2001)
DOI
ScienceOn
|
| 109 |
Fuiji, S., Yakohama, T., Ikegaya, K., Sato, F., and Yohoo, N., Promoting effect of the new chymotrypsin inhibitor FK-448 on the intestinal absorption of insulin in rats and dogs. J. Control. Rel., 13, 213-223 (1991)
|
| 110 |
Kratzel, M., Heissbock, R., and Bernkop-Schnurch, A., Auxiliary agents for the peroral administration of peptide and protein drugs: synthesis and evaluation of novel pepstatin analogues. J. Med. Chem., 41, 2339-2344, (1998)
DOI
ScienceOn
|
| 111 |
Bell, D. S. and Ovalle, F., Use of soy protein supplement and resultant need for increased dose of levothyroxine. Endocr. Prsct., 7, 193-194(2001)
DOI
ScienceOn
|
webmaster
